Solomon, S.R.; Powell, B.L.; Koprivnikar, J.; Lai, C.; Male, H.; Michaelis, L.C.; Newell, L.F.; Sanford, D.; Jenkins, J.; Zelaya, A.;
et al. CPX-351 Pharmacokinetics and Safety in Adults with Hematologic Malignancies and Renal Function Impairment: Phase 1 Trial. Cancers 2024, 16, 915.
https://doi.org/10.3390/cancers16050915
AMA Style
Solomon SR, Powell BL, Koprivnikar J, Lai C, Male H, Michaelis LC, Newell LF, Sanford D, Jenkins J, Zelaya A,
et al. CPX-351 Pharmacokinetics and Safety in Adults with Hematologic Malignancies and Renal Function Impairment: Phase 1 Trial. Cancers. 2024; 16(5):915.
https://doi.org/10.3390/cancers16050915
Chicago/Turabian Style
Solomon, Scott R., Bayard L. Powell, Jamie Koprivnikar, Catherine Lai, Heather Male, Laura C. Michaelis, Laura F. Newell, David Sanford, Jack Jenkins, Amy Zelaya,
and et al. 2024. "CPX-351 Pharmacokinetics and Safety in Adults with Hematologic Malignancies and Renal Function Impairment: Phase 1 Trial" Cancers 16, no. 5: 915.
https://doi.org/10.3390/cancers16050915
APA Style
Solomon, S. R., Powell, B. L., Koprivnikar, J., Lai, C., Male, H., Michaelis, L. C., Newell, L. F., Sanford, D., Jenkins, J., Zelaya, A., Coppola, S., Faderl, S., & Walter, R. B.
(2024). CPX-351 Pharmacokinetics and Safety in Adults with Hematologic Malignancies and Renal Function Impairment: Phase 1 Trial. Cancers, 16(5), 915.
https://doi.org/10.3390/cancers16050915
